U.S. federal trademark · Serial No. 90545043 · Reg. No. 8187837
Pharmaceutical preparations and substances, namely, RNA therapeutics for the treatment of infectious diseases, blood disorders, and inflammation; pharmaceutical preparations, namely, RNA therapeutics for the prevention of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, RNA therapeutics for the treatment of viral infections; pharmaceutical preparations, namely, RNA therapeutics for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, and infectious disorders; pharmaceutical preparations, namely, RNA therapeutics for use in chemotherapy; pharmaceutical preparations, namely, RNA therapeutics for cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; pharmaceutical preparations, namely, antivirals; therapeutic pharmaceuticals, namely, RNA therapeutics for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; vaccine preparations, namely, RNA vaccine preparations; vaccines, namely, RNA vaccines; human vaccine preparations, namely, RNA vaccine preparations; medical preparations for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparations, namely, RNA therapeutics for the prevention and treatment of infectious diseases; pharmaceutical preparations, namely, RNA therapeutics for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical products, namely, RNA therapeutics for the treatment of viral and infectious diseases, for the treatment of cancer; therapeutic vaccines, namely, RNA therapeutics; all of the foregoing excluding medicinal dietary and nutritional supplements
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.